The orexin (hypocretin) neurons play an essential role in promoting arousal, and loss of the orexin neurons results in narcolepsy, a condition characterized by chronic sleepiness and cataplexy. The orexin neurons excite wake-promoting neurons in the basal forebrain (BF), and a reciprocal projection from the BF back to the orexin neurons may help promote arousal and motivation. The BF contains at least three different cell types (cholinergic, glutamatergic, and g-aminobutyric acid (GABA)ergic neurons) across its different regions (medial septum, diagonal band, magnocellular preoptic area, and substantia innominata). Given the neurochemical and anatomical heterogeneity of the BF, we mapped the pattern of BF projections to the orexin neurons across multiple BF regions and neuronal types. We performed conditional anterograde tracing using mice that express Cre recombinase only in neurons producing acetylcholine, glutamate, or GABA. We found that the orexin neurons are heavily apposed by axon terminals of glutamatergic and GABAergic neurons of the substantia innominata (SI) and magnocellular preoptic area, but there was no innervation by the cholinergic neurons.
Crocker, & Scammell, 2006; Henny & Jones, 2006a ) and other subcortical targets (Swanson, Mogenson, Gerfen, & Robinson, 1984; Semba, 2000) . Orexin neurons are essential for maintaining wakefulness and regulating REM sleep, and extensive loss of the orexin neurons results in narcolepsy (Chemelli et al., 1999; Thannickal et al., 2000; Peyron et al., 2000) characterized by excessive daytime sleepiness and cataplexy. Many researchers have proposed that the orexin neurons promote arousal by exciting wake-active neurons in the BF (Fadel & Frederick-Duus, 2008; Jones, 2008; Arrigoni, Mochizuki, & Scammell, 2010; Saper et al., 2010) , and we hypothesize that reciprocal projections from the BF back to the orexin neurons may further promote arousal and other shared functions.
Previous studies have examined these descending projections using conventional tracers, but these methods may have limited sensitivity as they require double immunolabeling of nerve terminals (Gautron, Lazarus, Scott, Saper, & Elmquist, 2010) . More importantly, prior research has not mapped whether these descending projections to the orexin neurons vary across BF nuclei or whether these pathways actually influence the activity of the orexin neurons. To map these descending projections to the orexin neurons, we used conditional anterograde tracing of BF neurons producing acetylcholine, GABA, or glutamate. We then tested the functions of these projections in vitro using Channelrhodopsin-assisted circuit mapping (CRACM).
| MATERIALS A ND METHODS

| Animals
We used female Cre-expressing mice weighing 20 to 30 g (n 5 15-20 of each line). These recombinant mice have very similar designs, with an IRES-Cre cassette inserted just after the stop codon of the genes coding for choline acetyltransferase (ChAT), vesicular glutamate transporter 2 (vGluT2), or vesicular GABA transporter (vGAT). The vGATand vGluT2-Cre mice have been previously validated and show excellent alignment of vGAT and vGluT2 mRNA with recombinase activity in a reporter line (Vong et al., 2011) . Glutamate can be packaged into synaptic vesicles by vGluT1, vGluT2, or vGluT3, and in the BF, vGluT2 is the major vesicular glutamate transporter (Henny & Jones, 2006b; Harkany et al., 2003; Nickerson Poulin, Guerci, El Mestikawy, & Semba, 2006; www.alleninstitute.org) . vGAT transports GABA into synaptic vesicles, and vGAT-Cre mice show recombination only in GABAergic neurons. The ChAT-Cre mice have been validated in prior studies (Higley et al., 2011; Rossi et al., 2011) .
We housed these mice on a 12-hr:12-hr light:dark cycle with lights on at 0700 at 22 8C ambient temperature with ad libitum access to food and water. All protocols and care of the mice followed National
Institutes of Health guidelines and were approved by the Beth Israel Deaconess Medical Center Institutional Animal Care and Use Committee.
| Conditional anterograde tracing
We used conditional anterograde tracing to map projections from the three major populations of BF neurons to the orexin neurons. We injected the BF of Cre-expressing mice with an adeno-associated viral vector (AAV8-EF1a-DIO-hChR2(H134R)-mCherry, 6 3 10 12 pfu/ml, UNC Vector Core, Chapel Hill, NC) coding for Cre-dependent channelrhodopsin (ChR2) tagged with the red fluorescent protein mCherry (AAV-ChR2-mCherry). In this AAV, the ChR2-mCherry sequence is inverted and surrounded by pairs of loxP and lox2272 sites, thus preventing nonspecific expression of ChR2-mCherry. By injecting this AAV into mice that express Cre recombinase selectively in GABA (vGAT-Cre), glutamate (vGluT2-Cre), or acetylcholine (ChAT-Cre) neurons, ChR2-mCherry expression was limited just to neurochemically specific populations of BF neurons.
We anesthetized mice with ketamine/xylazine (100/10 mg/kg. i.p.) and unilaterally microinjected 3 to 6 nl of AAV-ChR2-mCherry into the (Canteras, Simerly, & Swanson, 1995; Heimer, Harlan, Alheid, Garcia, & de Olmos, 1997; Alheid, 2003) , and for simplicity, we use the term SI to describe the loosely packed, subcommissural group of neurons within the boundary of magnocellular cholinergic neurons dorsal to the more densely packed MCPO and HDB. Rostrocaudally, our SI injections ranged from the decussation of the anterior commissure back to the level of the caudal edge of the supraoptic nucleus.
Four weeks later, at around 10:00 am (3 hr after lights on), we deeply anesthetized mice with ketamine/xylazine (150/15 mg/kg i.p.)
and transcardially perfused them with 50 ml of phosphate-buffered saline (PBS; pH 7.4) followed by 50 ml of buffered 10% formalin (pH 7.0; Fisher Scientific, Fair Lawn, NJ). We removed and postfixed the brains for 12 hr in 10% formalin and then cryoprotected them in PBS containing 20% sucrose. We later coronally sectioned the brains at 30 lm into a 1:4 series on a freezing microtome.
| Immunohistochemistry
We defined the BF by the boundaries of the cholinergic population as others have done previously (Hedreen, Struble, Whitehouse, & Price, 1984; Schwaber, Rogers, Satoh, & Fibiger, 1987; Semba, 2000) . To establish that AAV-ChR2-mCherry injections were within the borders of the BF, we double-immunolabeled one series of sections from each mouse black for DsRed (which labels mCherry) and brown for ChAT with 3,3 0 -diaminobenzidine (DAB) (Figure 1 ). Methodological details such as PBS washes were followed as described in Yoshida et al. (2006) . In brief, we placed BF sections in 0.3% hydrogen peroxide prepared in PBT (PBS, pH 7.4, with 0.25% Triton X-100) for 30 min to inactivate endogenous peroxidases and then incubated them overnight in rabbit anti-DsRed (Clontech, Mountain View, CA, Cat# 632496, RRID: AB_10013483, rabbit, polyclonal) and goat anti-ChAT (Millipore, Billerica, MA, Cat# AB144P, RRID: AB_262156, goat, polyclonal) prepared in PBT with normal horse serum ( The GFP and DsRed antisera produced no labeling in wild-type mice lacking these peptides, and the orexin antisera produced no staining in orexin knockout mice. 
| Validation of neurochemical specificity
To confirm that mCherry was expressed only in the correct types of neurons, we immunolabeled BF sections for mCherry and markers of cholinergic, glutamatergic, and GABAergic neurons.
We incubated BF sections from ChAT-Cre mice overnight in rabbit anti-DsRed (1:2,000) and goat anti-ChAT (1:1,000). The next day, we We imaged whole sections using an Olympus VS120 slide scanner at a (1:500; Jackson ImmunoResearch, Cat# 703-545-155) for 1 hr to stain YFP-containing soma green. We then imaged tissue using a confocal microscope and counted cells. We found that 93% and 99% of the YFP-labeled cells were also labeled for vGluT2 and vGAT, respectively.
For Figure 2 , we collapsed the confocal stacks into one image using the Z Project function in ImageJ.
To 
| Analysis of anterograde tracing
We targeted our injections at the MS, HDB, MCPO, or SI and then selected cases that were limited to each part of the BF (n 5 3 for each region and for each Cre line). Criteria for inclusion were that the injection was confined to the boundaries of the cholinergic BF neurons. We excluded 7/47 cases as misses and used them as anatomical controls to contrast with BF injections. These controls included injections in the globus pallidus and preoptic area.
We plotted injection sites onto template drawings representing three levels of the BF (Figure 3 ). Specifically, we scanned BF sections using brightfield on a slide scanner (Olympus VS120; UPlanSApo 10 3 objective, 0.40 numerical aperture [NA] ) and traced the center of the injection site onto a template using Photoshop (Adobe, San Jose, CA). The center of the injection site was defined as the section in the middle of the rostrocaudal extent of the injection, and then we traced around the entire border of the transfected cells.
To quantify innervation of the orexin neurons, we counted the number of orexin neurons apposed by mCherry-labeled synaptic boutons. First, we selected sections from the rostral, central, and caudal parts of the orexin field spaced 240 mm apart ( Figure 4A ). To determine if a cell was apposed by a nerve terminal from the BF, we examined each orexin neuron containing a nucleus using brightfield microscopy (Zeiss Axioplan 2; 100 3 oil objective [Plan-Neofluar 1.3 NA] with a Zeiss achromatic-aplanatic universal condenser 0.9), adjusting the focus to maximize visibility of appositions. An orexin neuron was considered innervated if there was at least one mCherry-labeled bouton immediately adjacent to the soma or proximal dendrites ( Figure 4B ).
On a photomicrograph of the section, we marked each orexin neuron with a blue dot if it was innervated or a red dot if it was not ( Figure 5 ).
To examine regional changes across the orexin field, we counted appositions in the three rostral-caudal levels and also in the lateral, perifornical, and medial parts of the orexin field.
| Confocal microscopy and analysis
We used confocal microscopy to confirm that BF neurons form close appositions on orexin neurons. First, we fluorescently labeled LH sections green for orexin and red for the mCherry-filled BF terminals. We then photographed double-labeled sections in 1-mm optical sections using a Zeiss LSM 510 META confocal microscope with a Zeiss PlanApoChromat 63 3 oil objective (1.4 NA). We scrolled through the 20 z- stack images using ImageJ (NIH, Bethesda, MD) and counted orexin neurons that received at least one BF apposition immediately adjacent to the soma and proximal dendrites. We used Photoshop to adjust brightness and contrast when needed, and in some images, we pseudocolored red as magenta.
| Synaptophysin labeling
To establish further whether the anatomical appositions form synapses, we labeled presynaptic terminals with mCherry fused to synaptophysin, a presynaptic vesicle glycoprotein (Rizzoli, 2014) . Using the same three lines of mice, we injected the SI with an AAV coding for Credependent synaptophysin fused to mCherry (AAV8-hEF1a-DIO-synaptophysin-mCherry-WPRE) (Garfield et al., 2014) . After 4 weeks, we perfused the mice and immunostained mCherry black with DAB-Ni and orexin neurons brown with DAB, using the protocol described above.
The synaptophysin-mCherry produced black punctate labeling of synaptic boutons with minimal labeling of axons, and we counted synaptophysin-immunolabeled boutons apposing orexin neurons as described above using the 100 3 oil objective.
| CRACM
To confirm that projections from the BF form functional synapses onto orexin neurons, we used in vitro CRACM with dual AAV injections. We unilaterally microinjected the SI of 7-to 9-week-old vGAT-Cre (n 5 7 mice) and vGluT2-Cre (n 5 7 mice, but 2 were excluded for missed injection sites) female mice with 3 to 6 nl of an AAV coding for ChR2 fused to enhanced yellow fluorescent protein (EYFP; AAV10-EF1a-DIO-hChR2(H134R)-EYFP; 1 3 10 12 pfu/ml; a kind gift of the Fuller Lab; Chen et al., 2015) . This conditional YFP labeled BF soma and terminals as strongly as the mCherry labeling used in other experiments.
To identify the orexin neurons in recording slices, we also injected the orexin field with an AAV in which a 1.3-kb fragment of the human prepro-orexin promoter drives expression of tdTomato (AAV8-horexintdTomato; 1.7 3 10 13 pfu/ml); the AAV construct was a kind gift of Takeshi Sakurai, Kanazawa University, Japan (Saito et al., 2013) . We We recorded 25 orexin neurons from across the medial-lateral extent of the orexin field in five vGluT2-Cre mice. We recorded 46 neurons (39 orexin neurons 1 7 non-orexin neurons) in seven vGAT-Cre mice.
We recorded an average of five to seven neurons per mouse.
To determine if AAV-horexin-tdTomato labels only orexin neurons, we fluorescently immunolabeled LH sections for DsRed and orexin, and found that 82% of the tdTomato-labeled neurons were also double-labeled for orexin. The tdTomato-labeled neurons lacking orexin were small (<10 mm) and ventral and lateral to the orexin field.
Therefore, our recordings targeted only large (>20 mm) tdTomatolabeled neurons in the orexin field, and all had the typical physiological characteristics previously described for orexin neurons (Schone, Venner, Knowles, Karnani, & Burdakov, 2011) .
Eight weeks after AAV injections, we prepared LH slices for electrophysiological recordings. We deeply anesthetized mice with isoflurane via inhalation at 10:00 am (3 hr after lights on), and transcardially perfused them with ice-cold cutting artificial cerebrospinal fluid (ACSF;
100 NMDG, 2.5 KCl, 1.24 NaH 2 PO 4 , 30 NaHCO 3 , 25 glucose, 20
HEPES, 2 thiourea, 5 Na-L-ascorbate, 3 Na-pyruvate, 0.5 CaCl 2 , 10
MgSO 4 (pH 7.3 with HCl when carbogenated with 95% O 2 and 5%
CO 2 ). We quickly removed the mouse brains and sectioned them in coronal slices (250 mm thick) in ice-cold cutting ACSF using a vibrating microtome (VT1000S, Leica, Bannockburn, IL). We transferred the slices containing the orexin field to normal ACSF containing (in mM): 120 NaCl, 2.5 KCl, 1.3 MgCl 2 , 10 glucose, 26 NaHCO 3 , 1.24 NaH 2 PO 4 , 4
CaCl 2 , 2 thiourea, 1 Na-L-ascorbate, 3 Na-pyruvate (pH 7.4 when carbogenated with 95% O 2 and 5% CO 2 , 310-320 mOsm).
We recorded from large neurons across the orexin field that expressed tdTomato using a combination of fluorescence and infra- (Hull, Adesnik, & Scanziani, 2009 ). We identified orexin neurons by expression of tdTomato and confirmed this based on their firing properties (Schone et al., 2011) .
We analyzed the electrophysiological data using Clampfit 9.0 (Molecular Devices) and IGOR Pro 6 (WaveMetrics, Lake Oswego, OR). We analyzed the synaptic events off-line using Mini Analysis 6 (Synaptosoft, Leonia, NJ). We calculated the latency of the photoevoked EPSCs and IPSCs as the time difference between the start of the light pulse and the 5% rise point of the first EPSC (Hull et al., 2009 ).
| Statistical analysis
We report data as mean 6 SEM. We used the Kruskal-Wallis rank sum test to compare cell counts between different levels of the orexin field, followed by a Dunn's multiple comparison test to identify significant pairwise differences (StatView, SAS Institute, Cary, NC).
| R E S U LTS
| Conditional anterograde tracing
We injected AAV-ChR2-mCherry into the BF of ChAT-Cre, vGluT2-Cre, and vGAT-Cre mice. The injection sites were small, with typical diameters of 720 to 960 mm (Figure 1 ). We double-labeled sections for mCherry and ChAT, and selected three cases limited to the MS, HDB, MCPO, or SI for each of the three lines of mice (Figures 2 and 3) . In
ChAT-Cre mice, all mCherry-containing neurons also labeled for ChAT.
In vGluT2-Cre and vGAT-Cre mice, mCherry never colocalized with
ChAT, demonstrating that the vGAT and vGluT2 neurons are distinct from the cholinergic neurons, as indicated in prior studies (Gritti et al., 2006; Xu et al., 2015) .
This method produced robust and selective anterograde labeling in GABAergic, glutamatergic, and cholinergic BF neurons, with the heaviest innervation of the orexin field arising from the lateral and caudal parts of the BF (SI and MCPO). We estimated the percentage of orexin neurons innervated by each BF cell type by counting the number of orexin neurons with at least one closely apposing bouton from each of the different BF areas ( Figure 4 and Table 2 ). While the identification of a single apposition on orexin neurons provided a minimal criterion for counting a neuron targeted by each BF region, most orexin neurons were apposed by multiple GABAergic and glutamatergic boutons. The
GABAergic and glutamatergic neurons also formed ascending projections to the cortex, hippocampus, and amygdala plus descending projections to many additional regions including the posterior hypothalamus, supramammillary nucleus, habenula, VTA, and parabrachial nucleus that we will describe in a separate report. Over the entire orexin field, the GABAergic and glutamatergic boutons originating from the SI formed close appositions on 89% 6 3% and 80% 6 1% of the orexin neurons, respectively ( Figure 5 and Table   2 ). The conditional tracing method also worked well in the cholinergic BF neurons, producing heavy labeling of axons to the cortex, hippocampus, basolateral amygdala, and other regions. However, within the orexin field, cholinergic axons were absent, and we found no orexin neurons with cholinergic appositions from the BF. Yoshida et al., 2006) , so we subdivided our mapping of glutamatergic and GABAergic appositions on orexin neurons into three medial to lateral divisions and three rostral-caudal levels. Boutons from GABAergic SI neurons formed close appositions on orexin neurons across the lateral, perifornical, and medial parts of the orexin field (95% 6 2%, 91% 6 3%, 84% 6 3%; P 5 0.11) ( Figure 5 ). In contrast, glutamatergic innervation was strong in the lateral field and moderate medially (91% 6 1%, 79% 6 1%, 63% 6 2%; P 5 0.03); pairwise comparisons showed significant differences between the lateral and medial divisions (P < 0.05). Across the rostral, mid, and caudal levels of the orexin field, there was little variation in the GABAergic innervation (91% 6 2%, 90% 6 3%, 87% 6 5%), and glutamatergic innervation (77% 6 2%, 79% 6 1%, and 85% 6 5%) of the orexin neurons.
Synaptophysin is a reliable marker of presynaptic protein complexes (Rizzoli, 2014) , and the frequency of appositions on orexin neu- We analyzed all confocal images to determine if the BF boutons labeled with ChR2-mCherry form close appositions on the orexin neurons. We acquired 20 images per z-stack and examined each 1-mm optical section for appositions. We acquired images in the lateral, perifornical, and medial aspects of the orexin field. We found that about 78% and 80% of the orexin neurons received glutamatergic and GABAergic appositions, respectively.
| Innervation of the orexin neurons by other BF regions
Innervation of the orexin neurons varied greatly across BF regions.
GABAergic and glutamatergic neurons of the MCPO innervated the orexin neurons almost as heavily as those of the SI, but innervation from the HDB and MS was light ( Figure 6 and Table 2 We placed control injection in the ventromedial globus pallidus (just dorsal to the SI), and we did not see projections to the orexin field.
Control injections into the lateral and medial preoptic area revealed strong projections to the ventral orexin field, so in analyzing our BF series, we excluded cases with any extension of tracer medial to the BF.
| CRACM of SI-to-orexin projections
We used CRACM to test for synaptic connectivity between glutamatergic and GABAergic neurons of the SI and the orexin neurons ( Figure   7 ). We injected AAV-ChR2-EYFP virus in the SI region and AAV- Orexin neurons demonstrated spontaneous IPSCs that were blocked by bicuculline (10 mM), but these events were not synchronized to photostimulation. As a positive control, we recorded from non-orexin neurons within the orexin field and found that short latency ( These findings suggest that feedback from BF glutamate neurons may regulate orexin neuron activity, but the GABAergic BF neurons appear to have little direct effect.
| Pattern of SI BF projections to the orexin neurons
The descending glutamatergic and GABAergic projections from the SI and MCPO densely innervate the LH. We found that the SI glutamatergic input is heaviest in the lateral part of the orexin field, but the GABAergic projection from the SI is uniformly strong across the entire orexin field. Studies investigating functional divisions among orexin neurons suggest that more medial orexin neurons are involved with arousal, whereas lateral orexin neurons are involved in reward-seeking behaviors (Estabrooke et al., 2001; Fadel, Bubser, & Deutch, 2002; Harris, Wimmer, & Aston-Jones, 2005; Harris & Aston-Jones, 2006 ). In addition, noncholinergic BF neurons fire in association with changes in sleep/wake states and also encode motivational salience (Lin & Nicolelis, 2008; Hassani, Lee, Henny, & Jones, 2009; Raver & Lin, 2015) . Perhaps the BF glutamatergic innervation of the orexin neurons that we describe mainly reinforces reward-seeking or motivated behaviors.
To confirm that these ChR2-mCherry appositions were true synaptic specializations, we used another conditional tracer in which mCherry is fused to synaptophysin and found that 79% and 77% of the orexin neurons received appositions from SI glutamatergic and GABAergic neurons, respectively. For comparison, ChR2-mCherry labeled glutamatergic and GABAergic appositions on 80% and 89% of the orexin neurons, respectively. The slightly lower numbers of appositions with the synaptophysin method may be due to lower transduction efficiency with this AAV or fewer false-positive appositions than in the ChR2 sections in which irregularities in axons occasionally resemble axon boutons.
| Variations in projections from different BF nuclei
We find that the heaviest BF projections to the orexin neurons arise from the most lateral and caudal parts of the BF, but innervation from medial and rostral BF regions is sparse to nonexistent. In fact, the lateral-medial dimension may be most important, as innervation is light from medial but relatively caudal regions such as the caudal HDB but moderately strong from the lateral but rostral part of the SI (data not shown). This pattern is in keeping with prior tracing studies in rats that showed moderate input to the orexin neurons from the SI but minimal to no input from the MS and HDB (Grove, 1988; Yoshida et al., 2006) .
Our small injections into specific BF regions further demonstrate the anatomical heterogeneity among BF subnuclei, especially the differences between the MCPO and HDB. These adjacent structures are defined by loose clusters of magnocellular cholinergic neurons (Dinopoulos, Parnavelas, & Eckenstein, 1986; Brashear, Zaborszky, & Heimer, 1986) , but their boundaries can be indistinct and they are often considered together. We find that neurons in the HDB innervate very few orexin neurons whereas slightly more lateral neurons in the MCPO form strong projections. These distinctions highlight the general topology of the hypothalamus and BF proposed by Swanson and others, which emphasizes anatomically and functionally distinct medial and lateral "columns" such that the lateral parts of the BF and the LH are anatomically and functionally linked (Swanson, 2000) .
While only the lateral parts of the BF innervate the orexin neurons, the orexin neurons innervate the entire BF including the medial septum (Peyron et al., 1998) , with preferential innervation of the BF from the medial orexin neurons (España, Reis, Valentino, & Berridge, 2005) . All BF regions express orexin receptors (Marcus et al., 2001) , and orexins (orexin-A and orexin-B) excite cholinergic and noncholinergic BF neurons in the medial septum, HDB, and MCPO (Eggermann et al., 2001; Wu, Zaborszky, Hajszan, van den Pol, & Alreja, 2004; Arrigoni et al., 2010) . In addition, microinjection of orexin-A into the MS or SI rapidly increases wake (España, Baldo, Kelley, & Berridge, 2001; Thakkar, Ramesh, Strecker, & McCarley, 2001) This difference in intensity of innervation could be due to species differences, size of injections, and location with the BF, but we suspect that conditional tracing is more sensitive, as conditional tracing produces large amounts of marker protein, and the method does not require double or triple labeling of nerve terminals. Future experiments should be able to establish which method is more sensitive by direct comparison of conditional and conventional tracers.
Although projections from glutamatergic and GABAergic BF neurons are very strong, we found that BF cholinergic neurons do not innervate the orexin neurons. One study using transgenic mice reported that cholinergic BF neurons innervated the orexin neurons (Sakurai et al., 2005) , but this may have been a methodological artifact as other studies using conventional anterograde and retrograde tracers found very little to no innervation by BF cholinergic neurons (Gritti, Mainville, & Jones, 1994; Henny & Jones, 2006a) . The orexin neurons are excited by the cholinergic agonist carbachol (Yamanaka, Muraki, Tsujino, Goto, & Sakurai, 2003; Bayer et al., 2005; Ohno, Hondo, & Sakurai, 2008) , but these cholinergic signals likely arise from other regions such as the pedunculopontine tegmental nucleus or the laterodorsal tegmental nucleus (Semba, Reiner, McGeer, & Fibiger, 1988; Hallanger & Wainer, 1988; Satoh & Fibiger, 1986) .
| Possible functions of the glutamatergic BF projection
Our study provides strong evidence that glutamatergic MCPO and SI neurons can excite the orexin neurons. Henny and colleagues (2006a) found that some orexin neurons contain the postsynaptic scaffolding protein PSD-95 opposite vGluT2-labeled boutons from the SI. We now show that about 80% of the orexin neurons are innervated by glutamatergic SI boutons, and about 80% of the orexin neurons respond to optogenetic stimulation of glutamatergic SI terminals.
Most research on the BF has focused on the cholinergic and GABAergic neurons, but much less is known about the functions of the glutamatergic BF neurons. Hassani and colleagues (2009) used extracellular recordings with juxtacellular labeling to study putative glutamatergic BF neurons in vivo, and found that these neurons are mainly active during wakefulness and REM sleep. Specifically, these noncholinergic, non-GABAergic neurons primarily fire in association with fast cortical rhythms, although a few may be more active during NREM sleep. A recent study (Xu et al., 2015) using optrode recordings in reporter mice confirms that these vGluT2 1 BF cells primarily fire during wake and REM sleep, and are less active during NREM sleep, and optogenetic activation of these neurons induced a rapid transition from NREM sleep to wakefulness.
The orexin neurons are clearly active during wake. In rodents, FOS studies plus juxtacellular and unit recordings show that orexin neurons are mostly active during wakefulness (Estabrooke et al., 2001; Mileykovskiy, Kiyashchenko, & Siegel, 2005; Lee, Hassani, & Jones, 2005) , and in humans, extracellular levels of orexin-A can be six times higher during wake than during sleep (Blouin et al., 2013) . In cats, brain and CSF orexin peptide concentrations are increased during wake (Kiyashchenko et al., 2002) . Furthermore, NMDA administration in the LH increases wakefulness in wild-type mice but less so in orexin knockout mice (Kostin, Siegel, & Alam, 2014) . Lastly, prolonged wakefulness and food deprivation increase EPSCs on orexin neurons (Horvath & Gao, 2005; Rao et al., 2007) .
Most likely, glutamatergic BF neurons and orexin neurons excite each other during wake, and this positive feedback promotes arousal.
Additionally, both the BF and orexin neurons have been implicated in motivated behaviors. As adequate arousal is required for all motivated behaviors, this circuit may promote both arousal and motivation.
| Possible functions of the GABAergic BF projection
With brightfield and fluorescence microscopy, GABAergic BF neurons formed numerous apparent synapses on orexin neurons, but CRACM showed few direct responses. This was unexpected, as these GABAergic boutons contain synaptophysin presynaptically, and Henny & Jones (2006) demonstrated that in rats, orexin neurons express the postsynaptic scaffolding protein gephyrin opposite boutons from BF GABAergic neurons, suggesting the presence of functional synapses. In addition, GABA can inhibit the orexin neurons (Yamanaka et al., 2003; Xie et al., 2006) , and photostimulation of GABAergic fibers from the POA rapidly inhibits the orexin neurons (Saito et al., 2013) . Most importantly, the CRACM method was clearly effective, as it elicited GABA release from SI terminals and short-latency IPSPs on adjacent non-orexin neurons. Sleep deprivation can increase the expression of GABA A receptors on orexin neurons (Toossi, Del Cid-Pellitero, & Jones, 2016) , and it is possible that CRACM would show stronger connectivity after sleep deprivation.
Researchers have long appreciated that light microscopy can suggest false-positive synaptic connectivity. For example, Meredith and Wouterlood (1990) found that hippocampal projections formed apparent appositions on cholinergic neurons in the nucleus accumbens when studied with light microscopy, but they could not detect any synaptic contacts with electron microscopy. Instead, the hippocampal projections synapsed on adjacent, noncholinergic neurons. Similarly, it seems most likely that the GABAergic terminals from the SI synapse on non-orexin LH neurons. In ongoing research, we are now examining whether these non-orexin neurons form a local circuit through which they influence the orexin neurons.
BF GABAergic neurons are functionally heterogeneous, and these populations may have distinct effects on the orexin and other LH neurons. GABAergic BF neurons can differ in their expression of peptides such as parvalbumin, calbindin, and somatostatin (Gritti, Manns, Mainville, & Jones, 2003; Xu et al., 2015) , basic membrane properties (McKenna et al., 2013) , and in vivo firing patterns (Hassani et al., 2009 (Satoh et al., 2003) , but a wake-active GABAergic projection onto the orexin neurons seems counterproductive for wake maintenance. Therefore, wake-active GABAergic neurons probably do not directly innervate the orexin neurons, but they may indirectly excite the orexin neurons via an inhibitory LH interneuron. Clearly, more work is needed to define the anatomy and functions of these large, descending GABAergic projections.
| Limitations
One potential limitation of our experiments is that we focused on glu- Thus, it is possible that some cholinergic BF neurons corelease glutamate, as has been shown in cholinergic interneurons in the striatum (Higley et al., 2011) . However, this is unlikely to be a glutamatergic influence on the orexin neurons, as cholinergic BF neurons do not innervate the orexin neurons in mice. In addition, we have seen no evidence of glutamate release from GABAergic BF neurons using optogenetics (present experiments and unpublished results).
Research on the SI is confounded by definitions that differ between research groups. Nomenclature to describe or subdivide this region includes the SI, ventral pallidum (VP), extended amydgala, nucleus basalis, and interstitial nucleus of the posterior limb of the anterior commissure (IPAC). While some refer to this entire region as the SI (Canteras et al., 1995) , others propose that the VP and extended amygdala are rostral and caudal divisions of the SI (Heimer et al., 1997; Alheid, 2003) . In part, this complexity arises from differences in BF anatomy across species, as cholinergic groups form tighter clusters and are defined differently in primates than in rodents. We operationally define the SI as the loosely packed subcommissural group of neurons within the boundary of magnocellular cholinergic neurons that are located dorsal to the more densely packed MCPO and HDB, and ventral/medial to the GP (Figure 3) . The basal nucleus, ventral pallidum, and extended amygdala, as described by others, may overlap with the region we define as the SI, or they may be distinct subregions. We appreciate the complexity of the nomenclature and the difficulty of categorizing the neurons in this area; hopefully, future research will identify specific neuronal markers to better define the SI, especially in relation to the VP and extended amygdala.
Another limitation is the challenge of tracing pathways in the small brains of mice. We injected very small (3-6 nl) volumes of AAV-ChR2-mCherry, but injections occasionally spread into adjacent parts of the BF. We managed this problem by limiting our analysis to injections confined to specific BF regions and within cholinergic boundaries, as is typical with many anatomical studies. Conversely, because our injections were small, our analyses may underestimate of the density of the projections from a given BF structure. precision in counting appositions, light microscopy is only a start for identifying potential synapses, and the presence of true synapses needs to be established using electron microscopy or electrophysiology.
| C O NC LU S I O N S
Glutamatergic and GABAergic neurons of the SI and MCPO send dense projections to the orexin neurons, and the glutamatergic synapses excite the orexin neurons while the GABA synapses appear to have weak direct connectivity (Figure 8 ). Considering the intensity of these projections, the BF and orexin neurons likely work in concert to promote arousal, motivation, and other behaviors.
ACKNOWLEDGMENTS
We appreciate much thoughtful feedback on anatomy from Dr. Clif
Saper. We thank Dr. Patrick Fuller for giving us the AAV-ChR2-YFP, and Dr. Takeshi Sakurai for his kind gift of the AAV construct for the AAV8-horexin-tdTomato.
CONFLICT OF INTEREST
None of the authors have any conflicts.
AUTHOR CONTRIBUTIONS
All authors had full access to all the data in the study and take 
